Novogene

Highly Engaged Employees

Novogene, founded in 2011, is a global leader in genomic services and bioinformatics solutions. The company specializes in next-generation sequencing (NGS) and maintains the world's largest sequencing capacity. By providing end-to-end genomic profiling, Novogene supports clinical research and personalized medicine through ultra-fast turnaround times and high-quality data output. Their technical expertise spans third-generation sequencing, gene expression profiling, and single-cell analysis, positioning them as a critical partner for B2B commercial services in the life sciences sector.

Operating across 7 global locations, Novogene maintains a robust workforce of 1,000-5,000 employees. The organization leverages its extensive infrastructure to deliver rapid, reliable genomic data to a diverse international client base. Meet Novogene's team to understand the leadership and technical expertise driving their operational success. Their commitment to innovation is reflected in their diverse service portfolio, which includes library preparation, whole-genome sequencing, and specialized animal and plant genomic studies. The company continues to scale its operations to meet the increasing demand for high-throughput sequencing and complex bioinformatics analysis in the global market.

Novogene has demonstrated significant market growth, reporting annual revenue of $379.5M. The company’s financial stability is supported by strategic capital, including a $75.0M Series B funding round led by Sigma Square Capital in 2016. This investment has enabled the expansion of their sequencing capacity and the development of advanced proprietary technologies. Explore financial highlights to review the company's fiscal performance and funding history. As a key player in the genomics industry, Novogene remains focused on scaling its technological capabilities to maintain its competitive edge inView more...